Axim Financial Statements From 2010 to 2024
| AXIM Stock | USD 0.01 0.0003 2.91% |
Check Axim Biotechnologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Axim main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Axim financial statements analysis is a perfect complement when working with Axim Biotechnologies Valuation or Volatility modules.
Axim |
Axim Biotechnologies OTC Stock Shares Outstanding Analysis
Axim Biotechnologies' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Axim Biotechnologies Shares Outstanding | 186.44 M |
Most of Axim Biotechnologies' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Axim Biotechnologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Axim Biotechnologies has 186.44 M of shares currently outstending. This is 3.27% higher than that of the Biotechnology sector and 74.48% higher than that of the Health Care industry. The shares outstanding for all United States stocks is 67.39% higher than that of the company.
Axim Biotechnologies Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Axim Biotechnologies's current stock value. Our valuation model uses many indicators to compare Axim Biotechnologies value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Axim Biotechnologies competition to find correlations between indicators driving Axim Biotechnologies's intrinsic value. More Info.Axim Biotechnologies is rated fifth in return on equity category among related companies. It is rated below average in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Axim Biotechnologies by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Axim Biotechnologies' OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Axim Biotechnologies' earnings, one of the primary drivers of an investment's value.About Axim Biotechnologies Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Axim Biotechnologies income statement, its balance sheet, and the statement of cash flows. Axim Biotechnologies investors use historical funamental indicators, such as Axim Biotechnologies's revenue or net income, to determine how well the company is positioned to perform in the future. Although Axim Biotechnologies investors may use each financial statement separately, they are all related. The changes in Axim Biotechnologies's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Axim Biotechnologies's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Axim Biotechnologies Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Axim Biotechnologies. Please read more on our technical analysis and fundamental analysis pages.
AXIM Biotechnologies, Inc. develops and sells diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and oncology. AXIM Biotechnologies, Inc. was incorporated in 2010 and is based in San Diego, California. Axim Biotechnologies operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 6 people.
Pair Trading with Axim Biotechnologies
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Axim Biotechnologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Axim Biotechnologies will appreciate offsetting losses from the drop in the long position's value.Moving against Axim OTC Stock
| 0.89 | JPM | JPMorgan Chase Financial Report 12th of July 2024 | PairCorr |
| 0.86 | BAC | Bank of America Sell-off Trend | PairCorr |
| 0.85 | CAT | Caterpillar Earnings Call Today | PairCorr |
| 0.82 | GE | GE Aerospace Financial Report 23rd of July 2024 | PairCorr |
| 0.81 | DD | Dupont De Nemours Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Axim Biotechnologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Axim Biotechnologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Axim Biotechnologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Axim Biotechnologies to buy it.
The correlation of Axim Biotechnologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Axim Biotechnologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Axim Biotechnologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Axim Biotechnologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Axim Biotechnologies Correlation against competitors. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Complementary Tools for Axim OTC Stock analysis
When running Axim Biotechnologies' price analysis, check to measure Axim Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Axim Biotechnologies is operating at the current time. Most of Axim Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Axim Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Axim Biotechnologies' price. Additionally, you may evaluate how the addition of Axim Biotechnologies to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |